Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

291 - 300of 392 News

May 13, 2019

Beiersdorf to acquire iconic Coppertone™ brand from Bayer

May 13, 2019

Not intended for U.S. and UK Media - 2019 American Society of Clinical Oncology (ASCO) Annual Meeting:

Bayer to present new data at ASCO 2019 highlighting commitment to evolve cancer treatment paradigm

April 29, 2019

Not intended for U.S. and UK Media

U.S. FDA accepts new drug application and grants priority review for darolutamide

April 29, 2019

Not intended for U.S. and UK Media

Study reaffirms safety and efficacy profile of Xarelto™ for the prevention of stroke in patients with atrial fibrillation

April 26, 2019

After Annual Stockholders’ Meeting votes to not ratify Board of Management’s actions:

Bayer’s Supervisory Board unanimously stands behind Board of Management

April 26, 2019

CEO Werner Baumann at the Annual Stockholders’ Meeting of Bayer AG:

"We made great progress - both operationally and strategically"

April 25, 2019

First quarter of 2019:

Bayer: strong operational start to the year

March 27, 2019

Bayer statement on jury’s decision in phase two of California glyphosate trial

March 25, 2019

Bayer reaches settlement to resolve Xarelto™ litigation

March 19, 2019

Bayer statement on jury’s decision in phase one of California glyphosate trial

Inform Yourself on Special Topics

Investor News and Updates

Control Weeds, Not Farming

Everything You Need to Know About Glyphosate

Managing Glyphosate Litigation

Managing and Mitigating PCB Litigation Risk